BearingPoint is B Corp Certified

 

TelEm Group Partners with iBASIS as Exclusive Provider for International Voice Termination in the Caribbean Islands of Sint Maarten, Antilles, Saba, and Sint Eustatius

 

“Charming Beijing” Exhibition Highlights World Cultural Heritage for European Audiences

 

Charge Your Curiosity With Shell Recharge’s Collaboration With Curiosity Stream

 

BM3EAC Corp. 2024 Semi-Annual Report

 

Wolters Kluwer Introduces New GenAI Functionality to VitalLaw Legal Research Platform

 

Hudson Therapeutics Announces Shaperon’s Entry $9.58 Billion Global Alopecia Areata Treatment Market

 

AM Best Affirms Credit Ratings of West of England Ship Owners Mutual Insurance Association

 

MesoPher Cell Therapy Increases 2-Year RFS Rate in Resected Pancreatic Cancer by 50%; Amphera Announces Publication of Phase II Results in Journal of Clinical Oncology and Orphan Designation Granted by FDA & EMA

 

New Data Show Almirall´s EBGLYSS® (Lebrikizumab) Provided Sustained Disease Control for up to Three Years in More Than 80% of Adults and Adolescents With Moderate-to-severe Atopic Dermatitis